Neonatal induction and maintenance of tolerance to Th2-induced immune manifestations in rats.
Field
A C
AC
INSERM U430, Hôpital Broussais, Paris, France.
Caccavelli
L
L
Fillion
J
J
Kuhn
J
J
Mandet
C
C
Bellon
B
B
D000818:Animals; D000831:Animals, Newborn; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D015704:CD4 Antigens / Q000276:immunology; D016827:CD8 Antigens / Q000276:immunology; D005260:Female; D007108:Immune Tolerance; D017493:Leukocyte Common Antigens / Q000276:immunology; D008198:Lymph Nodes / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D008627:Mercuric Chloride / Q000494:pharmacology*; D051381:Rats; D011914:Rats, Inbred BN; D015375:Receptors, Interleukin-2 / Q000276:immunology; D013154:Spleen / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology*
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D016827:CD8 Antigens; D015375:Receptors, Interleukin-2; D008627:Mercuric Chloride; D017493:Leukocyte Common Antigens